This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters To The Editor

Systematic Review of Lithium Augmentation in Depression Resistant to at Least 2 Antidepressants

Anand Jayaraman, MRCPsych, and Harpal Nandhra, MRCPsych

Published: August 19, 2009

Article Abstract

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

To the Editor: Refractory depression is common inclinical practice. At least 30% of patients fail to respond toinitial antidepressant therapy.1 In patients who have failed 1course of antidepressants, there is evidence from 9 randomizedcontrolled trials suggesting that approximately 50% oftreatment-refractory patients do respond to lithium augmentationcompared with placebo (p < .001).2


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 11

Quick Links: Depression (MDD)

References

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Effect of Zuranolone on Concurrent Anxiety and Insomnia Symptoms in Women With Postpartum Depression

Zuranolone was associated with improvements in depressive and anxiety symptoms and was beneficial for insomnia and patient-perceived...

Read More...